rs1682859

Variant names:

• chr11-133930324-C-A
• rs1682859
• NM_001277285.4:c.1520-542G>T

Your query was ambiguous. Multiple possible variants found:

• chr11-133930324-C-A
• chr11-133930324-C-G
• chr11-133930324-C-T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_Strong BA1

The NM_001277285.4(IGSF9B):​c.1520-542G>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.662 in 151,992 control chromosomes in the GnomAD database, including 33,683 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

• Frequency: Genomes: 𝑓 0.66 (33683 hom., cov: 32)
• Consequence: IGSF9B NM_001277285.4 intron
• Clinical Significance: Not reported in ClinVar
• Conservation: PhyloP100: -1.52
• Publications: 9 publications found

Genes affected

IGSF9B (HGNC:32326): (immunoglobulin superfamily member 9B) Predicted to enable kinase binding activity. Predicted to be involved in synaptic membrane adhesion. Predicted to act upstream of or within homophilic cell adhesion via plasma membrane adhesion molecules and positive regulation of inhibitory postsynaptic potential. Predicted to be located in dendrite; inhibitory synapse; and neuronal cell body. Predicted to be active in GABA-ergic synapse; neuron projection; and postsynaptic specialization of symmetric synapse. [provided by Alliance of Genome Resources, Apr 2022]

ACMG classification

Our verdict: Benign. The variant received -12 ACMG points.

• BP4: Computational evidence support a benign effect (BayesDel_noAF=-0.9).
• BA1: GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.683 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001277285.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.	Gene	Transcript	Tags	HGVSc	HGVSp	Effect	Exon Rank	Protein	UniProt
	IGSF9B	NM_001277285.4	MANE Select	c.1520-542G>T		intron	N/A	NP_001264214.1	Q9UPX0-2

Ensembl Transcripts

Sel.	Gene	Transcript	Tags	HGVSc	HGVSp	Effect	Exon Rank	Protein	UniProt
	IGSF9B	ENST00000533871.8	TSL:5 MANE Select	c.1520-542G>T		intron	N/A	ENSP00000436552.2	Q9UPX0-2
	IGSF9B	ENST00000321016.12	TSL:5	c.1520-542G>T		intron	N/A	ENSP00000317980.8	Q9UPX0-1
	IGSF9B	ENST00000527648.2	TSL:2	n.1250-542G>T		intron	N/A

Frequencies

GnomAD3 genomes AF: 0.662 AC: 100551 AN: 151874 Hom.: 33643 Cov.: 32

Gnomad AFR AF: 0.679

Gnomad AMI AF: 0.776

Gnomad AMR AF: 0.599

Gnomad ASJ AF: 0.660

Gnomad EAS AF: 0.332

Gnomad SAS AF: 0.602

Gnomad FIN AF: 0.695

Gnomad MID AF: 0.759

Gnomad NFE AF: 0.689

Gnomad OTH AF: 0.663

We have no GnomAD4 exomes data on this position. Probably position not covered by the project.

GnomAD4 genome AF: 0.662 AC: 100652 AN: 151992 Hom.: 33683 Cov.: 32 AF XY: 0.658 AC XY: 48850 AN XY: 74280

African (AFR) AF: 0.679 AC: 28136 AN: 41448

American (AMR) AF: 0.599 AC: 9156 AN: 15284

Ashkenazi Jewish (ASJ) AF: 0.660 AC: 2292 AN: 3472

East Asian (EAS) AF: 0.332 AC: 1705 AN: 5140

South Asian (SAS) AF: 0.602 AC: 2895 AN: 4806

European-Finnish (FIN) AF: 0.695 AC: 7345 AN: 10570

Middle Eastern (MID) AF: 0.765 AC: 225 AN: 294

European-Non Finnish (NFE) AF: 0.688 AC: 46784 AN: 67952

Other (OTH) AF: 0.665 AC: 1406 AN: 2114

Alfa AF: 0.670 Hom.: 52198

Bravo AF: 0.651

Asia WGS AF: 0.501 AC: 1745 AN: 3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name	Calibrated prediction	Score	Prediction
BayesDel_noAF	Benign	-0.90
CADD	Benign	0.62
DANN	Benign	0.41
PhyloP100		-1.5
Mutation Taster		=100/0	polymorphism (auto)

Splicing

Name	Calibrated prediction	Score	Prediction
SpliceAI score (max)		0.030		Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Other links and lift over

dbSNP: rs1682859; hg19: chr11-133800219;